Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

First Exon Donor Splice Variant: A Meta-analysis

ASHG 2024

American Society for Human Genetics

Denver, CO, Nov 5, 2024

Poster presentation: First Exon Donor Splice Variant: A Meta-analysis

Authors: Murdoch JD, Kurtz L, Maston G

Specialty: Genetics

Related content

Publication
Novel Variant Findings and Challenges Associated With the Clinical Integration
Conference Presentation
Developing a Streamlined and Sustainable Variant Curation Process: Experience From ClinGen’s Cardiomyopathy Variant Curation Expert Panel
Publication
Novel CTNNB1 Variant Leading to Neurodevelopmental Disorder with Spastic Diplegia and Visual Defects Plus Peripheral Neuropathy: A Case Report

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.